Proteomics and ovarian cancer: Integrating proteomics information into clinical care
- 1 June 2010
- journal article
- review article
- Published by Elsevier in Journal of Proteomics
- Vol. 73 (10) , 1864-1872
- https://doi.org/10.1016/j.jprot.2010.05.013
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypesBreast Cancer Research, 2009
- Beyond CA125: The Coming of Age of Ovarian Cancer BiomarkersBiomarkers in Medicine, 2009
- Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysisElectrophoresis, 2009
- Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer BiomarkersMolecular & Cellular Proteomics, 2009
- A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell linesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massPublished by Elsevier ,2009
- Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and BevacizumabClinical Cancer Research, 2008
- A data-mining approach to biomarker identification from protein profiles using discrete stationary wavelet transformJournal of Zhejiang University-SCIENCE B, 2008
- Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Phase II consortiaGynecologic Oncology, 2008
- A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancerCancer, 2007